铂-话题@MedSci

#铂#

382篇内容 | 6066人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737701, encodeId=f6d61e3770152, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO:三阴乳腺癌（TNBC）患者新辅助化疗后残留，铂类化疗对比卡培他滨的疗效和安全性：随机III期研究（ECOG-ACRIN EA1131）, objectType=article, longId=212420, objectId=c51c2124203e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c51c2124203e, replyNumber=0, likeNumber=92, createdTime=2021-11-22, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c51c2124203e, moduleTitle=JCO:三阴乳腺癌（TNBC）患者新辅助化疗后残留，铂类化疗对比卡培他滨的疗效和安全性：随机III期研究（ECOG-ACRIN EA1131）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c51c2124203e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737658, encodeId=8dd11e3765811, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet oncol：PARP抑制剂veliparib联合卡铂-紫杉醇治疗BRCA突变的晚期乳腺癌的疗效, objectType=article, longId=200007, objectId=6f2b20000e60, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2b20000e60, replyNumber=0, likeNumber=56, createdTime=2020-09-30, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2b20000e60, moduleTitle=Lancet oncol：PARP抑制剂veliparib联合卡铂-紫杉醇治疗BRCA突变的晚期乳腺癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2b20000e60)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737650, encodeId=e00b1e376509d, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性, objectType=article, longId=198495, objectId=ee0919849563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee0919849563, replyNumber=0, likeNumber=77, createdTime=2020-12-13, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee0919849563, moduleTitle=Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee0919849563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737678, encodeId=c6011e37678f3, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, objectType=article, longId=206078, objectId=28d22060e857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d22060e857, replyNumber=0, likeNumber=66, createdTime=2021-10-13, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d22060e857, moduleTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28d22060e857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737646, encodeId=35f11e37646e3, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究, objectType=article, longId=197253, objectId=32b119e253bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b119e253bc, replyNumber=0, likeNumber=53, createdTime=2021-06-20, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b119e253bc, moduleTitle=Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b119e253bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737662, encodeId=4e361e3766271, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Clin Cancer Res：顺铂诱导的严重神经毒性的临床和全基因组分析 , objectType=article, longId=201775, objectId=53b8201e75b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53b8201e75b6, replyNumber=0, likeNumber=77, createdTime=2021-04-16, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53b8201e75b6, moduleTitle=Clin Cancer Res：顺铂诱导的严重神经毒性的临床和全基因组分析 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53b8201e75b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737667, encodeId=39461e37667c1, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Cell Metab：中和GDF-15可减轻铂类化学药物引起的呕吐、厌食以及体重减轻, objectType=article, longId=203673, objectId=39e32036e326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39e32036e326, replyNumber=0, likeNumber=76, createdTime=2021-06-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39e32036e326, moduleTitle=Cell Metab：中和GDF-15可减轻铂类化学药物引起的呕吐、厌食以及体重减轻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39e32036e326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737670, encodeId=6f5a1e376706c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet oncol：ICON8试验| 卵巢、输卵管、腹膜癌经卡铂-紫杉醇一线新辅助化疗后的客观缓解率, objectType=article, longId=205053, objectId=bd212050532b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd212050532b, replyNumber=0, likeNumber=65, createdTime=2021-03-04, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd212050532b, moduleTitle=Lancet oncol：ICON8试验| 卵巢、输卵管、腹膜癌经卡铂-紫杉醇一线新辅助化疗后的客观缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd212050532b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737653, encodeId=42831e376533a, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Clin Cancer Res：Ganetespib联合培美曲塞+铂类治疗恶性胸膜间皮瘤, objectType=article, longId=198667, objectId=2f6b19866e72, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f6b19866e72, replyNumber=0, likeNumber=103, createdTime=2021-05-07, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f6b19866e72, moduleTitle=Clin Cancer Res：Ganetespib联合培美曲塞+铂类治疗恶性胸膜间皮瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f6b19866e72)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737681, encodeId=07ce1e3768171, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌, objectType=article, longId=206571, objectId=f4692065e14a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4692065e14a, replyNumber=0, likeNumber=67, createdTime=2021-09-21, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4692065e14a, moduleTitle=J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4692065e14a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737660, encodeId=c72e1e376606e, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Br J Cancer：顺铂治疗加速睾丸癌幸存者的血管老化, objectType=article, longId=200952, objectId=88eb2009522c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88eb2009522c, replyNumber=0, likeNumber=69, createdTime=2021-07-30, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88eb2009522c, moduleTitle=Br J Cancer：顺铂治疗加速睾丸癌幸存者的血管老化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88eb2009522c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737654, encodeId=e9ab1e3765428, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Clin Oncol：转移性鳞状非小细胞肺癌患者中使用卡铂-紫杉醇联合培博利珠单抗可改善患者的生活质量, objectType=article, longId=199699, objectId=d1b8199699d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1b8199699d0, replyNumber=0, likeNumber=49, createdTime=2020-10-07, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1b8199699d0, moduleTitle=J Clin Oncol：转移性鳞状非小细胞肺癌患者中使用卡铂-紫杉醇联合培博利珠单抗可改善患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1b8199699d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737657, encodeId=34741e3765701, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, objectType=article, longId=199985, objectId=72b119998516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b119998516, replyNumber=0, likeNumber=86, createdTime=2021-03-15, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b119998516, moduleTitle=Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b119998516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737669, encodeId=84e51e37669d1, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=欧盟批准Apealea®（紫杉醇胶束）治疗铂类敏感上皮性卵巢癌, objectType=article, longId=204982, objectId=3e1720498269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e1720498269, replyNumber=0, likeNumber=83, createdTime=2021-08-02, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e1720498269, moduleTitle=欧盟批准Apealea®（紫杉醇胶束）治疗铂类敏感上皮性卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e1720498269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737645, encodeId=0e081e376452c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=AACR 2020：PD-L1单抗Tecentriq联合卡铂和依托泊苷，可提高小细胞肺癌SCLC生存率, objectType=article, longId=196545, objectId=5a8619654517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a8619654517, replyNumber=0, likeNumber=63, createdTime=2021-04-08, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a8619654517, moduleTitle=AACR 2020：PD-L1单抗Tecentriq联合卡铂和依托泊苷，可提高小细胞肺癌SCLC生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a8619654517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737643, encodeId=d8ab1e37643a4, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Cancer：尼莫妥珠单抗+顺铂化放疗vs单纯顺铂化放疗治疗局部晚期头颈癌的效果, objectType=article, longId=196262, objectId=49081962624e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49081962624e, replyNumber=0, likeNumber=88, createdTime=2021-05-28, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49081962624e, moduleTitle=Cancer：尼莫妥珠单抗+顺铂化放疗vs单纯顺铂化放疗治疗局部晚期头颈癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49081962624e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737679, encodeId=a7eb1e3767923, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=J Clin Oncol：贝伐单抗+卡铂+紫杉醇可明显改善转移性粘膜黑色素瘤的预后, objectType=article, longId=206293, objectId=d65b206293e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d65b206293e7, replyNumber=0, likeNumber=86, createdTime=2021-06-18, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d65b206293e7, moduleTitle=J Clin Oncol：贝伐单抗+卡铂+紫杉醇可明显改善转移性粘膜黑色素瘤的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d65b206293e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737672, encodeId=d79d1e37672f9, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效, objectType=article, longId=205851, objectId=3ac1205851bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ac1205851bd, replyNumber=0, likeNumber=82, createdTime=2021-11-06, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ac1205851bd, moduleTitle=Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ac1205851bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737648, encodeId=2b741e37648f3, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Clini Cancer Res：纳武单抗治疗晚期铂耐药尿路上皮癌, objectType=article, longId=198081, objectId=67a5198081df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67a5198081df, replyNumber=0, likeNumber=58, createdTime=2020-10-03, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67a5198081df, moduleTitle=Clini Cancer Res：纳武单抗治疗晚期铂耐药尿路上皮癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67a5198081df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737647, encodeId=798d1e37647cd, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet oncol：卡博替尼治疗铂耐药的转移性尿路上皮癌, objectType=article, longId=197427, objectId=6caa19e42798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6caa19e42798, replyNumber=0, likeNumber=60, createdTime=2020-12-09, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6caa19e42798, moduleTitle=Lancet oncol：卡博替尼治疗铂耐药的转移性尿路上皮癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6caa19e42798)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂

2020-05-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO:三阴乳腺癌（TNBC）患者新辅助化疗后残留，铂类化疗对比卡培他滨的疗效和安全性：随机III期研究（ECOG-ACRIN EA1131）

2021-11-22

柳叶一刀 (审核中...)

前往app查看评论内容

#铂#

Lancet oncol：PARP抑制剂veliparib联合卡铂-紫杉醇治疗BRCA突变的晚期乳腺癌的疗效

2020-09-30

柳叶一刀 (审核中...)

前往app查看评论内容

#铂#

Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性

2020-12-13

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案

2021-10-13

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Gynecol Oncol：新诊断的卵巢癌、原发性腹膜癌和输卵管癌的静脉或腹膜内铂类化疗联合Veliparib和Bevacizumab的I期研究

2021-06-20

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Clin Cancer Res：顺铂诱导的严重神经毒性的临床和全基因组分析

2021-04-16

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Cell Metab：中和GDF-15可减轻铂类化学药物引起的呕吐、厌食以及体重减轻

2021-06-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet oncol：ICON8试验| 卵巢、输卵管、腹膜癌经卡铂-紫杉醇一线新辅助化疗后的客观缓解率

2021-03-04

柳叶一刀 (审核中...)

前往app查看评论内容

#铂#

Clin Cancer Res：Ganetespib联合培美曲塞+铂类治疗恶性胸膜间皮瘤

2021-05-07

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌

2021-09-21

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Br J Cancer：顺铂治疗加速睾丸癌幸存者的血管老化

2021-07-30

柳叶一刀 (审核中...)

前往app查看评论内容

#铂#

J Clin Oncol：转移性鳞状非小细胞肺癌患者中使用卡铂-紫杉醇联合培博利珠单抗可改善患者的生活质量

2020-10-07

柳叶一刀 (审核中...)

前往app查看评论内容

#铂#

Eur Urol：局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关

2021-03-15

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

欧盟批准Apealea®（紫杉醇胶束）治疗铂类敏感上皮性卵巢癌

2021-08-02

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

AACR 2020：PD-L1单抗Tecentriq联合卡铂和依托泊苷，可提高小细胞肺癌SCLC生存率

2021-04-08

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Cancer：尼莫妥珠单抗+顺铂化放疗vs单纯顺铂化放疗治疗局部晚期头颈癌的效果

2021-05-28

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

J Clin Oncol：贝伐单抗+卡铂+紫杉醇可明显改善转移性粘膜黑色素瘤的预后

2021-06-18

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效

2021-11-06

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Clini Cancer Res：纳武单抗治疗晚期铂耐药尿路上皮癌

2020-10-03

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet oncol：卡博替尼治疗铂耐药的转移性尿路上皮癌

2020-12-09

科室
- - 订阅+
  - 更多科室
工具
服务